Kaiming Li

499 total citations
14 papers, 402 citations indexed

About

Kaiming Li is a scholar working on Molecular Biology, Oncology and Biotechnology. According to data from OpenAlex, Kaiming Li has authored 14 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Biotechnology. Recurrent topics in Kaiming Li's work include Nanoplatforms for cancer theranostics (3 papers), Cancer Research and Treatments (2 papers) and Immune cells in cancer (2 papers). Kaiming Li is often cited by papers focused on Nanoplatforms for cancer theranostics (3 papers), Cancer Research and Treatments (2 papers) and Immune cells in cancer (2 papers). Kaiming Li collaborates with scholars based in China and United States. Kaiming Li's co-authors include Can Zhang, Lingjing Xue, Caoyun Ju, Siyuan Hou, Meixi Hao, Lulu Zhu, Weishuo Li, Yue Chen, Kenneth L. Rinehart and Vimal Kishore and has published in prestigious journals such as ACS Nano, Journal of Controlled Release and Science Translational Medicine.

In The Last Decade

Kaiming Li

14 papers receiving 396 citations

Peers

Kaiming Li
Kaiming Li
Citations per year, relative to Kaiming Li Kaiming Li (= 1×) peers María Julia Lamberti

Countries citing papers authored by Kaiming Li

Since Specialization
Citations

This map shows the geographic impact of Kaiming Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaiming Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaiming Li more than expected).

Fields of papers citing papers by Kaiming Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaiming Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaiming Li. The network helps show where Kaiming Li may publish in the future.

Co-authorship network of co-authors of Kaiming Li

This figure shows the co-authorship network connecting the top 25 collaborators of Kaiming Li. A scholar is included among the top collaborators of Kaiming Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaiming Li. Kaiming Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Wu, Yue, Yanyi Li, Kaiming Li, et al.. (2023). Vitamin D receptor (VDR) mediates the quiescence of activated hepatic stellate cells (aHSCs) by regulating M2 macrophage exosomal smooth muscle cell-associated protein 5 (SMAP-5). Journal of Zhejiang University SCIENCE B. 24(3). 248–261. 13 indexed citations
2.
Hao, Meixi, Lulu Zhu, Siyuan Hou, et al.. (2023). Sensitizing Tumors to Immune Checkpoint Blockage via STING Agonists Delivered by Tumor-Penetrating Neutrophil Cytopharmaceuticals. ACS Nano. 17(2). 1663–1680. 58 indexed citations
3.
Li, Kaiming, Yue Chen, Sijia Chen, et al.. (2022). Real-time detection of T cell activation by visualizing TCR nanoclusters with a cholesterol derived aggregation-induced emission probe. European Journal of Medicinal Chemistry. 247. 115073–115073. 4 indexed citations
4.
Li, Kaiming, et al.. (2022). Reprogrammed siTNFα/neutrophil cytopharmaceuticals targeting inflamed joints for rheumatoid arthritis therapy. Acta Pharmaceutica Sinica B. 13(2). 787–803. 20 indexed citations
5.
Li, Yiqun, Kaiming Li, Yan Zhao, et al.. (2022). Emodin-8-O-β-D-glucopyranoside, a natural hydroxyanthraquinone glycoside from plant, suppresses cancer cell proliferation via p21-CDKs-Rb axis. Toxicology and Applied Pharmacology. 438. 115909–115909. 1 indexed citations
7.
Li, Yanyi, Weishuo Li, Shijing Liu, et al.. (2021). Simultaneous blockage of contextual TGF-β by cyto-pharmaceuticals to suppress breast cancer metastasis. Journal of Controlled Release. 336. 40–53. 20 indexed citations
9.
Tang, Chunming, Qianqian Wang, Kaiming Li, et al.. (2021). A neutrophil-mimetic magnetic nanoprobe for molecular magnetic resonance imaging of stroke-induced neuroinflammation. Biomaterials Science. 9(15). 5247–5258. 32 indexed citations
10.
Hao, Meixi, Siyuan Hou, Weishuo Li, et al.. (2020). Combination of metabolic intervention and T cell therapy enhances solid tumor immunotherapy. Science Translational Medicine. 12(571). 142 indexed citations
11.
Li, Yong, Yiqun Li, Dengke Li, et al.. (2020). Repositioning of Hypoglycemic Drug Linagliptin for Cancer Treatment. Frontiers in Pharmacology. 11. 187–187. 14 indexed citations
12.
Li, Kaiming, et al.. (2020). <p>The Expression of IgG and IgG4 in Orbital MALT Lymphoma: The Similarities and Differences of IgG4-Related Diseases</p>. OncoTargets and Therapy. Volume 13. 5755–5761. 10 indexed citations
13.
Li, Kaiming, et al.. (2017). Construction and protective immunogenicity of DNA vaccine pNMB0315 against Neisseria�meningitidis serogroup B. Molecular Medicine Reports. 17(2). 3178–3185. 4 indexed citations
14.
Rinehart, Kenneth L., et al.. (1988). Didemnins and Tunichlorin: Novel Natural Products from the Marine Tunicate Trididemnum solidum. Journal of Natural Products. 51(1). 1–21. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026